|
|
|
|
|
|
|
|
|
|
|
̵ |
Ǿǰ ǰ(GMP) ̴(ο ȳ)( 2) ߰ ˸
ľó Ǿǰ GMP ص ̰ ü ȯ濡 GMP ý ֵ, PIC/S, WHO, ICH ⱸ ̱, , Ϻ GMP ̵ հϿ Ǿǰ GMP ̴(ο ȳ)(2) ߰Ͽ. ̹ ̴ Ե GMP ȳ(3) ........
|
|
|
ȳ |
˱⽬ GMP (ο ȳ)
GMP ˱⽱ Ͽ Ǿǰ ǰ ڿ ǰ .........
|
|
|
/ |
[Ǿǰ ǰɻ ̵ ] ǰȸ (6/15())
ǰǾǰ Ǿǰ ϰ ϴ ü ǰ ؾ װ (CTD) Ǿǰ ۼ ϱ Ͽ [Ǿǰ ǰɻ ̵] . ̿ 2017 6 15ϱ ǰ ϰ .
[Ǿǰ ǰɻ ̵]
: 2017 6 15()
: info@kobia.kr
: 02-2088-3382
ڼ ÷ ........
|
|
|
ڷ |
ľó ο б ָް ִ ߵ Ȳ ' ' ߰.........
|
|
|
|
|
û |
|
ǰ |
ӻ |
ܰ |
ĸӼƼøġҽÿڸ |
20170605 |
HBeAg B ȯڿ ī Ǵ ׳ ΰμ FP-02.2 , ༺, 鿪 ϱ 1, , ߴ, , ٱ, 뷮 ӻ |
1 |
FP-02.2 |
̿ġ쾲ڸȸ |
20170531 |
ġ PD-L1+ ༺ Ǵ ̼ λǼ 汤 ȯڸ BGB-A317 ϱ, ٱ, 2 |
2 |
BGB-A317 |
()۶ҽ̽Ŭ |
20170530 |
ִ ο ġῡ ߰Ǵ 100 mg SC ָ ӻ ȿ ϴ , , ౺ 3 ӻ |
3 |
ָ |
()̿ġ̿ |
20170530 |
ߵ ̻ Ʊ Ǻο ȯڸ ̵(ADSTEM Inj.) ϱ |
1 |
̵ |
|
|
|
|
|
|
|
|
FDA |
|
Drug Name and
FDA Appl. # |
Active Ingredients |
Submission
Classification |
Company |
Approval Date |
ZERVIATE
NDA #208694 |
CETIRIZINE HYDROCHLORIDE |
ſ뷮 |
NICOX OPHTHALMICS INC |
05/30/2017 |
|
|
|
|
|
|
|
|
EMA |
|
Name |
Active Substance |
Therapeutic Area |
Dafe of
Authorisation
/ refusal |
Varuby |
rolapitant |
Cancer
Nausea
Vomiting |
20/04/2017 |
Pemetrexed Hospira UK Limited |
pemetrexed ditromethamine |
Carcinoma,
Non-Small-Cell Lung
Mesothelioma |
24/04/2017 |
Ivabradine Accord |
ivabradine hydrochloride |
Angina Pectoris
Heart Failure |
22/05/2017 |
|
|
|
|
|
|
|
|
Clinical.gov ̱ |
NCT
Number |
Title |
Conditions |
Interventions |
Sponsor
/Collaborators |
Phases |
NCT03174197 |
Atezolizumab (aPDL1) + Temozolomide and Radiation for Newly Diagnosed Glioblastoma (GBM) |
Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System
Glioblastoma
Gliosarcoma |
Drug: Temozolomide
Drug: Atezolizumab
Radiation: Radiation Therapy |
M.D. Anderson
Cancer Center
Genentech, Inc. |
Phase 1
Phase 2 |
NCT03173937 |
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome |
Severe Aplastic Anemia
Hypo-Plastic MDS
Myelodysplastic Syndrome (MDS) |
Biological: CordIn(TM) |
National Heart, Lung, and Blood Institute (NHLBI)
National Institutes of Health Clinical Center (CC) |
Phase 1
Phase 2 |
NCT03173950 |
Immune Checkpoint Inhibitor Nivolumab in People With Select Rare CNS Cancers |
Ependymoma
Meningioma
Chordoma |
Drug: Nivolumab |
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC) |
Phase 2 |
NCT03172624 |
Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer |
Salivary Gland Cancer |
Drug: Nivolumab
Drug: Ipilimumab |
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb |
Phase 2 |
|
|
|
|
Clinical.gov ߱ |
NCT
Number |
Title |
Conditions |
Interventions |
Sponsor
/Collaborators |
Phases |
NCT03173417 |
Safety and Efficacy Evaluation of IM19 CAR-T Cells (IM19CAR-T) |
Leukemia |
Biological: IM19 CAR-T |
Beijing Immunochina Medical Science & Technology Co., Ltd. |
Phase 1
Phase 2 |
|
|
|
|
Clinical.gov Ϻ |
NCT
Number |
Title |
Conditions |
Interventions |
Sponsor
/Collaborators |
Phases |
NCT03172819 |
Special Combination of OBP-301 and Pembrolizumab |
Advanced Solid Tumor |
Biological: OBP-301
Drug: Pembrolizumab |
Toshihiko Doi
Oncolys BioPharma Inc
National Cancer Center Hospital East |
Phase 1 |
|
|
|
|
|
|
|
Z̿ǽ, Ȳݺ ġ ̿ùз SB11
|
Z̿ǽ Ȳݺ ġ ̿ùз(̿Ǿǰ ) ߿ Ѵ. Ȳݺ Ǹ 1 ȯ̴. 4 迡 Z̿ǽ ֱ Ȳݺ ġ 缾Ƽ(и Ϻָ) ̿ùз SB11 ӻ 3 ȹ ̱ ӻƮ ߴ......
|
|
|
|
|
|
|
|
|
̿IT÷ Ʈ (6 9ϱ)
|
2017 ()ѱ̿Ǿǰȸ ǰǾǰó Բ ̿Ǿǰ ؿ ϱ Ͻ Ʈ(ؿ(̱//߱) 㰡 ) մϴ. ο Բ ̿Ǿǰ ؿ ϰ åǽİ е Ź 帳ϴ.
|
|
̿Ǿǰ ؿ(㰡) ǿ(̱//߱) |
|
ִ 3 |
|
6 2() ~ 6 9() 16:00, 7 |
|
̸(bpis@kobia.kr)
* Ȩ ε |
ǥ |
6 13 (ȭ) 뺸 |
|
Ȩ ȮϽñ ٶϴ.
()ѱ̿Ǿǰȸ : www.kobia.kr
̿IT÷ : www.bpis.or.kr |
|
|
|
|
|
|
|
2017 ̿IT÷ SNS İ ˸
|
ѱ̿Ǿǰȸ 14 ǰǾǰó ȯ ̿Ǿǰ ؿ ؿ ϴ ̿IT÷(www.bpis.or.kr/) ϰ , ս Ͻ ֵ ̿IT÷ SNS Ͽϴ.
ں Ǵ ش о в ȷο ϼż ϰ ҽ(Ʈ ˸) ƺð پ Ͻñ ٶϴ.
|
<̿IT÷ > |
- ( ֿ 15 /̵)
- ؿ 15 㰡 ü( û )
- ̿Ǿǰ ۷ι
- ֿ䱹 Ǿǰ
- ̿Ǿǰ 㰡 (Ϲ) û
|
- ۷ι (ֽ ̵ Ȳ)
- (ӻ, 㰡, )
- ؿ ̿Ǿǰ ֿ (CRO )
- 6 8 Ǿǰ |
|
|
|
|
|
|
|
|
|
|
|
|
|